カテゴリー： Market Monitor Global, 世界, 医療/バイオ

医療用抗真菌剤の世界市場見通し2023年-2029年

◆英語タイトル：Medical Antifungal Agent Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23JU5743）

◆商品コード：MMG23JU5743
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年6月（※2025年版があります。お問い合わせください。）
◆ページ数：114
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医薬品＆医療

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥468,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥608,400	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥702,000	見積依頼/購入/質問フォーム

★Market Monitor Globalに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Medical Antifungal Agent Market 調査レポートは次の情報を含め、グローバルにおけるの医療用抗真菌剤市場規模と予測を収録しています。・世界の医療用抗真菌剤市場：売上、2018年-2023年、2024年-2029年
・世界の医療用抗真菌剤市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の医療用抗真菌剤市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「アゾール類」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

医療用抗真菌剤のグローバル主要企業は、Novartis、 Pfizer、 Bayer、 Sanofi、 Merck & Co、 GlaxoSmithKline、 MSD Manuals、 Abbott、 Glenmark、 Enzon Pharmaceuticals、 Astellas Pharma、 Scynexis、 Cidara Therapeutics、 Lucigen Corporation、 Biosergen、 F2G、 Sichuan Meidakang Pharmaceutical、 Chengdu Taihe Health Technologyなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、医療用抗真菌剤のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界の医療用抗真菌剤市場：タイプ別、2018年-2023年、2024年-2029年
世界の医療用抗真菌剤市場：タイプ別市場シェア、2022年
・アゾール類、エキノカンジン類、ポリエン類、アリルアミン類、その他

世界の医療用抗真菌剤市場：用途別、2018年-2023年、2024年-2029年
世界の医療用抗真菌剤市場：用途別市場シェア、2022年
・皮膚糸状菌症、アスペルギルス症、カンジダ症、その他

世界の医療用抗真菌剤市場：地域・国別、2018年-2023年、2024年-2029年
世界の医療用抗真菌剤市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業における医療用抗真菌剤のグローバル売上、2018年-2023年
・主要企業における医療用抗真菌剤のグローバル売上シェア、2022年
・主要企業における医療用抗真菌剤のグローバル販売量、2018年-2023年
・主要企業における医療用抗真菌剤のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Novartis、 Pfizer、 Bayer、 Sanofi、 Merck & Co、 GlaxoSmithKline、 MSD Manuals、 Abbott、 Glenmark、 Enzon Pharmaceuticals、 Astellas Pharma、 Scynexis、 Cidara Therapeutics、 Lucigen Corporation、 Biosergen、 F2G、 Sichuan Meidakang Pharmaceutical、 Chengdu Taihe Health Technology

*************************************************************

・調査・分析レポートの概要
医療用抗真菌剤市場の定義
市場セグメント
世界の医療用抗真菌剤市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の医療用抗真菌剤市場規模
世界の医療用抗真菌剤市場規模：2022年 VS 2029年
世界の医療用抗真菌剤市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの医療用抗真菌剤の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の医療用抗真菌剤製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：アゾール類、エキノカンジン類、ポリエン類、アリルアミン類、その他
医療用抗真菌剤のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：皮膚糸状菌症、アスペルギルス症、カンジダ症、その他
医療用抗真菌剤の用途別グローバル売上・予測

・地域別市場分析
地域別医療用抗真菌剤市場規模 2022年と2029年
地域別医療用抗真菌剤売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Novartis、 Pfizer、 Bayer、 Sanofi、 Merck & Co、 GlaxoSmithKline、 MSD Manuals、 Abbott、 Glenmark、 Enzon Pharmaceuticals、 Astellas Pharma、 Scynexis、 Cidara Therapeutics、 Lucigen Corporation、 Biosergen、 F2G、 Sichuan Meidakang Pharmaceutical、 Chengdu Taihe Health Technology
...

Antifungals are medicines that kill or stop the growth of fungi that cause infections.
This report aims to provide a comprehensive presentation of the global market for Medical Antifungal Agent, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Medical Antifungal Agent. This report contains market size and forecasts of Medical Antifungal Agent in global, including the following market information:
Global Medical Antifungal Agent Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Medical Antifungal Agent Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Medical Antifungal Agent companies in 2022 (%)
The global Medical Antifungal Agent market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Azoles Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Medical Antifungal Agent include Novartis, Pfizer, Bayer, Sanofi, Merck & Co, GlaxoSmithKline, MSD Manuals, Abbott and Glenmark, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Medical Antifungal Agent manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Medical Antifungal Agent Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Medical Antifungal Agent Market Segment Percentages, by Type, 2022 (%)
Azoles
Echinocandins
Polyenes
Allylamines
Others
Global Medical Antifungal Agent Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Medical Antifungal Agent Market Segment Percentages, by Application, 2022 (%)
Dermatophytosis
Aspergillosis
Candidiasis
Others
Global Medical Antifungal Agent Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Medical Antifungal Agent Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Medical Antifungal Agent revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Medical Antifungal Agent revenues share in global market, 2022 (%)
Key companies Medical Antifungal Agent sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Medical Antifungal Agent sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis
Pfizer
Bayer
Sanofi
Merck & Co
GlaxoSmithKline
MSD Manuals
Abbott
Glenmark
Enzon Pharmaceuticals
Astellas Pharma
Scynexis
Cidara Therapeutics
Lucigen Corporation
Biosergen
F2G
Sichuan Meidakang Pharmaceutical
Chengdu Taihe Health Technology
Outline of Major Chapters:
Chapter 1: Introduces the definition of Medical Antifungal Agent, market overview.
Chapter 2: Global Medical Antifungal Agent market size in revenue and volume.
Chapter 3: Detailed analysis of Medical Antifungal Agent manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Medical Antifungal Agent in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Medical Antifungal Agent capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Medical Antifungal Agent Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Medical Antifungal Agent Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Medical Antifungal Agent Overall Market Size
2.1 Global Medical Antifungal Agent Market Size: 2022 VS 2029
2.2 Global Medical Antifungal Agent Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Medical Antifungal Agent Sales: 2018-2029
3 Company Landscape
3.1 Top Medical Antifungal Agent Players in Global Market
3.2 Top Global Medical Antifungal Agent Companies Ranked by Revenue
3.3 Global Medical Antifungal Agent Revenue by Companies
3.4 Global Medical Antifungal Agent Sales by Companies
3.5 Global Medical Antifungal Agent Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Medical Antifungal Agent Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Medical Antifungal Agent Product Type
3.8 Tier 1, Tier 2 and Tier 3 Medical Antifungal Agent Players in Global Market
3.8.1 List of Global Tier 1 Medical Antifungal Agent Companies
3.8.2 List of Global Tier 2 and Tier 3 Medical Antifungal Agent Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Medical Antifungal Agent Market Size Markets, 2022 & 2029
4.1.2 Azoles
4.1.3 Echinocandins
4.1.4 Polyenes
4.1.5 Allylamines
4.1.6 Others
4.2 By Type – Global Medical Antifungal Agent Revenue & Forecasts
4.2.1 By Type – Global Medical Antifungal Agent Revenue, 2018-2023
4.2.2 By Type – Global Medical Antifungal Agent Revenue, 2024-2029
4.2.3 By Type – Global Medical Antifungal Agent Revenue Market Share, 2018-2029
4.3 By Type – Global Medical Antifungal Agent Sales & Forecasts
4.3.1 By Type – Global Medical Antifungal Agent Sales, 2018-2023
4.3.2 By Type – Global Medical Antifungal Agent Sales, 2024-2029
4.3.3 By Type – Global Medical Antifungal Agent Sales Market Share, 2018-2029
4.4 By Type – Global Medical Antifungal Agent Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Medical Antifungal Agent Market Size, 2022 & 2029
5.1.2 Dermatophytosis
5.1.3 Aspergillosis
5.1.4 Candidiasis
5.1.5 Others
5.2 By Application – Global Medical Antifungal Agent Revenue & Forecasts
5.2.1 By Application – Global Medical Antifungal Agent Revenue, 2018-2023
5.2.2 By Application – Global Medical Antifungal Agent Revenue, 2024-2029
5.2.3 By Application – Global Medical Antifungal Agent Revenue Market Share, 2018-2029
5.3 By Application – Global Medical Antifungal Agent Sales & Forecasts
5.3.1 By Application – Global Medical Antifungal Agent Sales, 2018-2023
5.3.2 By Application – Global Medical Antifungal Agent Sales, 2024-2029
5.3.3 By Application – Global Medical Antifungal Agent Sales Market Share, 2018-2029
5.4 By Application – Global Medical Antifungal Agent Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Medical Antifungal Agent Market Size, 2022 & 2029
6.2 By Region – Global Medical Antifungal Agent Revenue & Forecasts
6.2.1 By Region – Global Medical Antifungal Agent Revenue, 2018-2023
6.2.2 By Region – Global Medical Antifungal Agent Revenue, 2024-2029
6.2.3 By Region – Global Medical Antifungal Agent Revenue Market Share, 2018-2029
6.3 By Region – Global Medical Antifungal Agent Sales & Forecasts
6.3.1 By Region – Global Medical Antifungal Agent Sales, 2018-2023
6.3.2 By Region – Global Medical Antifungal Agent Sales, 2024-2029
6.3.3 By Region – Global Medical Antifungal Agent Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Medical Antifungal Agent Revenue, 2018-2029
6.4.2 By Country – North America Medical Antifungal Agent Sales, 2018-2029
6.4.3 US Medical Antifungal Agent Market Size, 2018-2029
6.4.4 Canada Medical Antifungal Agent Market Size, 2018-2029
6.4.5 Mexico Medical Antifungal Agent Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Medical Antifungal Agent Revenue, 2018-2029
6.5.2 By Country – Europe Medical Antifungal Agent Sales, 2018-2029
6.5.3 Germany Medical Antifungal Agent Market Size, 2018-2029
6.5.4 France Medical Antifungal Agent Market Size, 2018-2029
6.5.5 U.K. Medical Antifungal Agent Market Size, 2018-2029
6.5.6 Italy Medical Antifungal Agent Market Size, 2018-2029
6.5.7 Russia Medical Antifungal Agent Market Size, 2018-2029
6.5.8 Nordic Countries Medical Antifungal Agent Market Size, 2018-2029
6.5.9 Benelux Medical Antifungal Agent Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Medical Antifungal Agent Revenue, 2018-2029
6.6.2 By Region – Asia Medical Antifungal Agent Sales, 2018-2029
6.6.3 China Medical Antifungal Agent Market Size, 2018-2029
6.6.4 Japan Medical Antifungal Agent Market Size, 2018-2029
6.6.5 South Korea Medical Antifungal Agent Market Size, 2018-2029
6.6.6 Southeast Asia Medical Antifungal Agent Market Size, 2018-2029
6.6.7 India Medical Antifungal Agent Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Medical Antifungal Agent Revenue, 2018-2029
6.7.2 By Country – South America Medical Antifungal Agent Sales, 2018-2029
6.7.3 Brazil Medical Antifungal Agent Market Size, 2018-2029
6.7.4 Argentina Medical Antifungal Agent Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Medical Antifungal Agent Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Medical Antifungal Agent Sales, 2018-2029
6.8.3 Turkey Medical Antifungal Agent Market Size, 2018-2029
6.8.4 Israel Medical Antifungal Agent Market Size, 2018-2029
6.8.5 Saudi Arabia Medical Antifungal Agent Market Size, 2018-2029
6.8.6 UAE Medical Antifungal Agent Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Novartis
7.1.1 Novartis Company Summary
7.1.2 Novartis Business Overview
7.1.3 Novartis Medical Antifungal Agent Major Product Offerings
7.1.4 Novartis Medical Antifungal Agent Sales and Revenue in Global (2018-2023)
7.1.5 Novartis Key News & Latest Developments
7.2 Pfizer
7.2.1 Pfizer Company Summary
7.2.2 Pfizer Business Overview
7.2.3 Pfizer Medical Antifungal Agent Major Product Offerings
7.2.4 Pfizer Medical Antifungal Agent Sales and Revenue in Global (2018-2023)
7.2.5 Pfizer Key News & Latest Developments
7.3 Bayer
7.3.1 Bayer Company Summary
7.3.2 Bayer Business Overview
7.3.3 Bayer Medical Antifungal Agent Major Product Offerings
7.3.4 Bayer Medical Antifungal Agent Sales and Revenue in Global (2018-2023)
7.3.5 Bayer Key News & Latest Developments
7.4 Sanofi
7.4.1 Sanofi Company Summary
7.4.2 Sanofi Business Overview
7.4.3 Sanofi Medical Antifungal Agent Major Product Offerings
7.4.4 Sanofi Medical Antifungal Agent Sales and Revenue in Global (2018-2023)
7.4.5 Sanofi Key News & Latest Developments
7.5 Merck & Co
7.5.1 Merck & Co Company Summary
7.5.2 Merck & Co Business Overview
7.5.3 Merck & Co Medical Antifungal Agent Major Product Offerings
7.5.4 Merck & Co Medical Antifungal Agent Sales and Revenue in Global (2018-2023)
7.5.5 Merck & Co Key News & Latest Developments
7.6 GlaxoSmithKline
7.6.1 GlaxoSmithKline Company Summary
7.6.2 GlaxoSmithKline Business Overview
7.6.3 GlaxoSmithKline Medical Antifungal Agent Major Product Offerings
7.6.4 GlaxoSmithKline Medical Antifungal Agent Sales and Revenue in Global (2018-2023)
7.6.5 GlaxoSmithKline Key News & Latest Developments
7.7 MSD Manuals
7.7.1 MSD Manuals Company Summary
7.7.2 MSD Manuals Business Overview
7.7.3 MSD Manuals Medical Antifungal Agent Major Product Offerings
7.7.4 MSD Manuals Medical Antifungal Agent Sales and Revenue in Global (2018-2023)
7.7.5 MSD Manuals Key News & Latest Developments
7.8 Abbott
7.8.1 Abbott Company Summary
7.8.2 Abbott Business Overview
7.8.3 Abbott Medical Antifungal Agent Major Product Offerings
7.8.4 Abbott Medical Antifungal Agent Sales and Revenue in Global (2018-2023)
7.8.5 Abbott Key News & Latest Developments
7.9 Glenmark
7.9.1 Glenmark Company Summary
7.9.2 Glenmark Business Overview
7.9.3 Glenmark Medical Antifungal Agent Major Product Offerings
7.9.4 Glenmark Medical Antifungal Agent Sales and Revenue in Global (2018-2023)
7.9.5 Glenmark Key News & Latest Developments
7.10 Enzon Pharmaceuticals
7.10.1 Enzon Pharmaceuticals Company Summary
7.10.2 Enzon Pharmaceuticals Business Overview
7.10.3 Enzon Pharmaceuticals Medical Antifungal Agent Major Product Offerings
7.10.4 Enzon Pharmaceuticals Medical Antifungal Agent Sales and Revenue in Global (2018-2023)
7.10.5 Enzon Pharmaceuticals Key News & Latest Developments
7.11 Astellas Pharma
7.11.1 Astellas Pharma Company Summary
7.11.2 Astellas Pharma Medical Antifungal Agent Business Overview
7.11.3 Astellas Pharma Medical Antifungal Agent Major Product Offerings
7.11.4 Astellas Pharma Medical Antifungal Agent Sales and Revenue in Global (2018-2023)
7.11.5 Astellas Pharma Key News & Latest Developments
7.12 Scynexis
7.12.1 Scynexis Company Summary
7.12.2 Scynexis Medical Antifungal Agent Business Overview
7.12.3 Scynexis Medical Antifungal Agent Major Product Offerings
7.12.4 Scynexis Medical Antifungal Agent Sales and Revenue in Global (2018-2023)
7.12.5 Scynexis Key News & Latest Developments
7.13 Cidara Therapeutics
7.13.1 Cidara Therapeutics Company Summary
7.13.2 Cidara Therapeutics Medical Antifungal Agent Business Overview
7.13.3 Cidara Therapeutics Medical Antifungal Agent Major Product Offerings
7.13.4 Cidara Therapeutics Medical Antifungal Agent Sales and Revenue in Global (2018-2023)
7.13.5 Cidara Therapeutics Key News & Latest Developments
7.14 Lucigen Corporation
7.14.1 Lucigen Corporation Company Summary
7.14.2 Lucigen Corporation Business Overview
7.14.3 Lucigen Corporation Medical Antifungal Agent Major Product Offerings
7.14.4 Lucigen Corporation Medical Antifungal Agent Sales and Revenue in Global (2018-2023)
7.14.5 Lucigen Corporation Key News & Latest Developments
7.15 Biosergen
7.15.1 Biosergen Company Summary
7.15.2 Biosergen Business Overview
7.15.3 Biosergen Medical Antifungal Agent Major Product Offerings
7.15.4 Biosergen Medical Antifungal Agent Sales and Revenue in Global (2018-2023)
7.15.5 Biosergen Key News & Latest Developments
7.16 F2G
7.16.1 F2G Company Summary
7.16.2 F2G Business Overview
7.16.3 F2G Medical Antifungal Agent Major Product Offerings
7.16.4 F2G Medical Antifungal Agent Sales and Revenue in Global (2018-2023)
7.16.5 F2G Key News & Latest Developments
7.17 Sichuan Meidakang Pharmaceutical
7.17.1 Sichuan Meidakang Pharmaceutical Company Summary
7.17.2 Sichuan Meidakang Pharmaceutical Business Overview
7.17.3 Sichuan Meidakang Pharmaceutical Medical Antifungal Agent Major Product Offerings
7.17.4 Sichuan Meidakang Pharmaceutical Medical Antifungal Agent Sales and Revenue in Global (2018-2023)
7.17.5 Sichuan Meidakang Pharmaceutical Key News & Latest Developments
7.18 Chengdu Taihe Health Technology
7.18.1 Chengdu Taihe Health Technology Company Summary
7.18.2 Chengdu Taihe Health Technology Business Overview
7.18.3 Chengdu Taihe Health Technology Medical Antifungal Agent Major Product Offerings
7.18.4 Chengdu Taihe Health Technology Medical Antifungal Agent Sales and Revenue in Global (2018-2023)
7.18.5 Chengdu Taihe Health Technology Key News & Latest Developments
8 Global Medical Antifungal Agent Production Capacity, Analysis
8.1 Global Medical Antifungal Agent Production Capacity, 2018-2029
8.2 Medical Antifungal Agent Production Capacity of Key Manufacturers in Global Market
8.3 Global Medical Antifungal Agent Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Medical Antifungal Agent Supply Chain Analysis
10.1 Medical Antifungal Agent Industry Value Chain
10.2 Medical Antifungal Agent Upstream Market
10.3 Medical Antifungal Agent Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Medical Antifungal Agent Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Medical Antifungal Agent in Global Market
Table 2. Top Medical Antifungal Agent Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Medical Antifungal Agent Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Medical Antifungal Agent Revenue Share by Companies, 2018-2023
Table 5. Global Medical Antifungal Agent Sales by Companies, (K Units), 2018-2023
Table 6. Global Medical Antifungal Agent Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Medical Antifungal Agent Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Medical Antifungal Agent Product Type
Table 9. List of Global Tier 1 Medical Antifungal Agent Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Medical Antifungal Agent Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Medical Antifungal Agent Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Medical Antifungal Agent Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Medical Antifungal Agent Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Medical Antifungal Agent Sales (K Units), 2018-2023
Table 15. By Type - Global Medical Antifungal Agent Sales (K Units), 2024-2029
Table 16. By Application – Global Medical Antifungal Agent Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Medical Antifungal Agent Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Medical Antifungal Agent Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Medical Antifungal Agent Sales (K Units), 2018-2023
Table 20. By Application - Global Medical Antifungal Agent Sales (K Units), 2024-2029
Table 21. By Region – Global Medical Antifungal Agent Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Medical Antifungal Agent Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Medical Antifungal Agent Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Medical Antifungal Agent Sales (K Units), 2018-2023
Table 25. By Region - Global Medical Antifungal Agent Sales (K Units), 2024-2029
Table 26. By Country - North America Medical Antifungal Agent Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Medical Antifungal Agent Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Medical Antifungal Agent Sales, (K Units), 2018-2023
Table 29. By Country - North America Medical Antifungal Agent Sales, (K Units), 2024-2029
Table 30. By Country - Europe Medical Antifungal Agent Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Medical Antifungal Agent Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Medical Antifungal Agent Sales, (K Units), 2018-2023
Table 33. By Country - Europe Medical Antifungal Agent Sales, (K Units), 2024-2029
Table 34. By Region - Asia Medical Antifungal Agent Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Medical Antifungal Agent Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Medical Antifungal Agent Sales, (K Units), 2018-2023
Table 37. By Region - Asia Medical Antifungal Agent Sales, (K Units), 2024-2029
Table 38. By Country - South America Medical Antifungal Agent Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Medical Antifungal Agent Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Medical Antifungal Agent Sales, (K Units), 2018-2023
Table 41. By Country - South America Medical Antifungal Agent Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Medical Antifungal Agent Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Medical Antifungal Agent Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Medical Antifungal Agent Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Medical Antifungal Agent Sales, (K Units), 2024-2029
Table 46. Novartis Company Summary
Table 47. Novartis Medical Antifungal Agent Product Offerings
Table 48. Novartis Medical Antifungal Agent Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Novartis Key News & Latest Developments
Table 50. Pfizer Company Summary
Table 51. Pfizer Medical Antifungal Agent Product Offerings
Table 52. Pfizer Medical Antifungal Agent Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Pfizer Key News & Latest Developments
Table 54. Bayer Company Summary
Table 55. Bayer Medical Antifungal Agent Product Offerings
Table 56. Bayer Medical Antifungal Agent Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Bayer Key News & Latest Developments
Table 58. Sanofi Company Summary
Table 59. Sanofi Medical Antifungal Agent Product Offerings
Table 60. Sanofi Medical Antifungal Agent Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Sanofi Key News & Latest Developments
Table 62. Merck & Co Company Summary
Table 63. Merck & Co Medical Antifungal Agent Product Offerings
Table 64. Merck & Co Medical Antifungal Agent Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. Merck & Co Key News & Latest Developments
Table 66. GlaxoSmithKline Company Summary
Table 67. GlaxoSmithKline Medical Antifungal Agent Product Offerings
Table 68. GlaxoSmithKline Medical Antifungal Agent Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. GlaxoSmithKline Key News & Latest Developments
Table 70. MSD Manuals Company Summary
Table 71. MSD Manuals Medical Antifungal Agent Product Offerings
Table 72. MSD Manuals Medical Antifungal Agent Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. MSD Manuals Key News & Latest Developments
Table 74. Abbott Company Summary
Table 75. Abbott Medical Antifungal Agent Product Offerings
Table 76. Abbott Medical Antifungal Agent Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. Abbott Key News & Latest Developments
Table 78. Glenmark Company Summary
Table 79. Glenmark Medical Antifungal Agent Product Offerings
Table 80. Glenmark Medical Antifungal Agent Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. Glenmark Key News & Latest Developments
Table 82. Enzon Pharmaceuticals Company Summary
Table 83. Enzon Pharmaceuticals Medical Antifungal Agent Product Offerings
Table 84. Enzon Pharmaceuticals Medical Antifungal Agent Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 85. Enzon Pharmaceuticals Key News & Latest Developments
Table 86. Astellas Pharma Company Summary
Table 87. Astellas Pharma Medical Antifungal Agent Product Offerings
Table 88. Astellas Pharma Medical Antifungal Agent Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 89. Astellas Pharma Key News & Latest Developments
Table 90. Scynexis Company Summary
Table 91. Scynexis Medical Antifungal Agent Product Offerings
Table 92. Scynexis Medical Antifungal Agent Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 93. Scynexis Key News & Latest Developments
Table 94. Cidara Therapeutics Company Summary
Table 95. Cidara Therapeutics Medical Antifungal Agent Product Offerings
Table 96. Cidara Therapeutics Medical Antifungal Agent Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 97. Cidara Therapeutics Key News & Latest Developments
Table 98. Lucigen Corporation Company Summary
Table 99. Lucigen Corporation Medical Antifungal Agent Product Offerings
Table 100. Lucigen Corporation Medical Antifungal Agent Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 101. Lucigen Corporation Key News & Latest Developments
Table 102. Biosergen Company Summary
Table 103. Biosergen Medical Antifungal Agent Product Offerings
Table 104. Biosergen Medical Antifungal Agent Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 105. Biosergen Key News & Latest Developments
Table 106. F2G Company Summary
Table 107. F2G Medical Antifungal Agent Product Offerings
Table 108. F2G Medical Antifungal Agent Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 109. F2G Key News & Latest Developments
Table 110. Sichuan Meidakang Pharmaceutical Company Summary
Table 111. Sichuan Meidakang Pharmaceutical Medical Antifungal Agent Product Offerings
Table 112. Sichuan Meidakang Pharmaceutical Medical Antifungal Agent Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 113. Sichuan Meidakang Pharmaceutical Key News & Latest Developments
Table 114. Chengdu Taihe Health Technology Company Summary
Table 115. Chengdu Taihe Health Technology Medical Antifungal Agent Product Offerings
Table 116. Chengdu Taihe Health Technology Medical Antifungal Agent Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 117. Chengdu Taihe Health Technology Key News & Latest Developments
Table 118. Medical Antifungal Agent Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 119. Global Medical Antifungal Agent Capacity Market Share of Key Manufacturers, 2021-2023
Table 120. Global Medical Antifungal Agent Production by Region, 2018-2023 (K Units)
Table 121. Global Medical Antifungal Agent Production by Region, 2024-2029 (K Units)
Table 122. Medical Antifungal Agent Market Opportunities & Trends in Global Market
Table 123. Medical Antifungal Agent Market Drivers in Global Market
Table 124. Medical Antifungal Agent Market Restraints in Global Market
Table 125. Medical Antifungal Agent Raw Materials
Table 126. Medical Antifungal Agent Raw Materials Suppliers in Global Market
Table 127. Typical Medical Antifungal Agent Downstream
Table 128. Medical Antifungal Agent Downstream Clients in Global Market
Table 129. Medical Antifungal Agent Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Medical Antifungal Agent Segment by Type in 2022
Figure 2. Medical Antifungal Agent Segment by Application in 2022
Figure 3. Global Medical Antifungal Agent Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Medical Antifungal Agent Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Medical Antifungal Agent Revenue, 2018-2029 (US$, Mn)
Figure 7. Medical Antifungal Agent Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Medical Antifungal Agent Revenue in 2022
Figure 9. By Type - Global Medical Antifungal Agent Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Medical Antifungal Agent Revenue Market Share, 2018-2029
Figure 11. By Type - Global Medical Antifungal Agent Sales Market Share, 2018-2029
Figure 12. By Type - Global Medical Antifungal Agent Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Medical Antifungal Agent Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Medical Antifungal Agent Revenue Market Share, 2018-2029
Figure 15. By Application - Global Medical Antifungal Agent Sales Market Share, 2018-2029
Figure 16. By Application - Global Medical Antifungal Agent Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Medical Antifungal Agent Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Medical Antifungal Agent Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Medical Antifungal Agent Revenue Market Share, 2018-2029
Figure 20. By Region - Global Medical Antifungal Agent Sales Market Share, 2018-2029
Figure 21. By Country - North America Medical Antifungal Agent Revenue Market Share, 2018-2029
Figure 22. By Country - North America Medical Antifungal Agent Sales Market Share, 2018-2029
Figure 23. US Medical Antifungal Agent Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Medical Antifungal Agent Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Medical Antifungal Agent Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Medical Antifungal Agent Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Medical Antifungal Agent Sales Market Share, 2018-2029
Figure 28. Germany Medical Antifungal Agent Revenue, (US$, Mn), 2018-2029
Figure 29. France Medical Antifungal Agent Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Medical Antifungal Agent Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Medical Antifungal Agent Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Medical Antifungal Agent Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Medical Antifungal Agent Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Medical Antifungal Agent Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Medical Antifungal Agent Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Medical Antifungal Agent Sales Market Share, 2018-2029
Figure 37. China Medical Antifungal Agent Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Medical Antifungal Agent Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Medical Antifungal Agent Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Medical Antifungal Agent Revenue, (US$, Mn), 2018-2029
Figure 41. India Medical Antifungal Agent Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Medical Antifungal Agent Revenue Market Share, 2018-2029
Figure 43. By Country - South America Medical Antifungal Agent Sales Market Share, 2018-2029
Figure 44. Brazil Medical Antifungal Agent Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Medical Antifungal Agent Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Medical Antifungal Agent Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Medical Antifungal Agent Sales Market Share, 2018-2029
Figure 48. Turkey Medical Antifungal Agent Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Medical Antifungal Agent Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Medical Antifungal Agent Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Medical Antifungal Agent Revenue, (US$, Mn), 2018-2029
Figure 52. Global Medical Antifungal Agent Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Medical Antifungal Agent by Region, 2022 VS 2029
Figure 54. Medical Antifungal Agent Industry Value Chain
Figure 55. Marketing Channels

※参考情報

医療用抗真菌剤は、真菌感染症の治療および予防に用いられる薬剤であり、さまざまな病気を引き起こす真菌に対抗するために開発されています。真菌は自然界に広く分布している微生物であり、その中には人間に対して病原性を持つものもいれば、有益なものもあります。しかし、特定の条件下では、病原性真菌が過剰に増殖し、免疫力が低下している人々や高齢者、病気により免疫抑制を受けている患者に対し、深刻な健康問題を引き起こすことがあります。

抗真菌剤は、大きく二つのカテゴリーに分けることができます。ひとつは、真菌の細胞膜や細胞壁に作用し、真菌を殺す「殺真菌剤」と呼ばれるものです。もうひとつは、真菌の増殖を抑える「静菌剤」であり、真菌の成長を制御することで感染拡大を防ぎます。これらの抗真菌剤は、異なる作用機序を持っており、特定の真菌に対して効果的なものとされています。

医療用抗真菌剤の主な種類には、アゾール系、ポリエン系、エキノカンジン系、フルコナゾール、アムホテリシンB、カスパフンジンなどがあります。アゾール系は、真菌の細胞膜に含まれるエルゴステロールの合成を阻害し、細胞膜の構造を崩すことで有害な影響を与えます。このため、カンジダ症やクリプトコッカス症などの治療に広く使用されています。

ポリエン系抗真菌剤には、アムホテリシンBがあり、これは真菌の細胞膜に直接結合し、細胞膜の透過性を高めて最終的に細胞死を引き起こします。特に重篤な真菌感染に対して用いられ、主に入院患者や免疫抑制患者に処方されます。

エキノカンジン系抗真菌剤は、真菌の細胞壁の合成を阻害することで作用します。このグループにはカスパフンジンが含まれ、特にカンジダやアスペルギルス感染症に効果的です。

抗真菌剤は、院内感染や免疫抑制患者に対して特に重要な役割を果たしています。これらの患者は、通常の免疫機能が弱く、真菌による感染が致命的な結果をもたらすことがあります。また、抗真菌剤は特定の治療プロトコルに従った使用が求められるため、病院内での適切な管理が必要です。

抗真菌剤の選択は、感染症の種類、患者の健康状態、過去の治療歴などを考慮して行われます。近年では、抗真菌剤に対する耐性が問題視されており、耐性菌の出現を防ぐための研究が進められています。耐性の問題は、特に長期入院患者や慢性疾患を持つ患者において顕著であり、より効果的な治療法の開発が急務とされています。

関連技術として、迅速診断技術の進展が挙げられます。従来は真菌の同定に時間がかかることが多かったですが、PCR技術や遺伝子配列解析などが進歩することで、迅速かつ正確に真菌を特定し、適切な抗真菌剤を選択することが可能となりました。このような技術の進展は、抗真菌治療の成功率を高める要因となります。

また、抗真菌剤の投与方法には、経口、静脈注射、局所投与などさまざまな手段があります。患者の状態や感染の重症度によって、最適な投与方法が選択されます。たとえば、局所感染に対しては、局所的に抗真菌剤を投与することが有効ですが、全身的な感染が疑われる場合には静脈内投与が行われます。

さらには、最近の研究では、組織工学やナノテクノロジーを活用した新しい抗真菌剤の開発も進められています。これらの技術により、抗真菌剤の効果を向上させ、同時に副作用を軽減することが期待されています。例えば、特定の細胞にターゲティングできるナノ粒子を用いることで、効果的かつ安全な抗真菌療法が実現する可能性があります。

医療用抗真菌剤は、現代の医療において欠かせない重要な治療手段であり、真菌感染症による健康被害を防ぐために常に進化し続けています。今後も新しい抗真菌剤の開発や、耐性菌対策、迅速診断技術の進展に注目し、効果的な治療プロトコルを確立するための努力が求められます。これにより、真菌感染症に対する戦いはますます強化され、患者の健康と安全を守るための新たな道を切り開いていくことでしょう。

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 医療用抗真菌剤の世界市場見通し2023年-2029年(Medical Antifungal Agent Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。

GlobalResearch.jp

医療用抗真菌剤の世界市場見通し2023年-2029年

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 www.GlobalResearch.jp